Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...
Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...
Myocardial infarction (MI) causes millions of deaths worldwide. Though there have been advances in the survival rates following ST-elevation MI (STEMI), survivors often develop heart failure due to ...
Myocardial ischemia, also called cardiac ischemia, is a condition characterized by reduced blood flow to the heart. A common cause is plaque buildup in the coronary arteries. Myocardial ischemia may ...
Test your knowledge of ECG interpretation with this ready-made quiz. Study up on a variety of Cardiology topics with Learn the Heart on Healio. Whether you're studying for the boards or just want to ...
Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results